
    
      The investigators will randomized 60 patients with stage 1 or 2 thumb osteoarthritis in two
      groups. The investigators will prescribe a neoprene CMC orthosis for patients in Group 1 and
      a thermoplastic CMC orthosis for patients in Group 2. The investigators will recommend these
      orthosis for six weeks. They will assess pain and disability before and after the treatment.
    
  